350+ Exhibitors from 16 countries set to showcase the best of healthcare technologies and equipment to 15,000+ attendees Indian healthcare landscape is witnessing dynamic changes, driven by a combination of technological advancements, policy reforms, and evolving healthcare needs. Innovations such as telemedicine and digital health solutions
Apollo Diagnostics, a division of Apollo Health and Lifestyle Limited (AHLL) and one of India's leading Diagnostic Centre & Pathology Lab, has launched four new centers across Pune, Maharashtra in Kalyani Nagar, Baner, Ravet and Kothrud. With a total of 1700 centers operational across India &
Torus Health, a venture of Cosmea Financial Holdings Pvt Ltd, has collaborated with PharmEasy to revolutionise the healthcare industry in India by offering a range of unparalleled services. This collaboration between Torus Health and PharmEasy, one of India’s most trusted online pharmacy services, will create
Emerges as the ONLY Healthcare Marketing Platform that ensures Real-Time Programmatic message delivery across POC platforms triggered by clinical data, AT SCALE The largest global marketing platform to reach 5 M+ HCPs across 25+ countries through 4000+ marketing campaigns Doceree, the leading global healthcare
In an epoch-making milestone, Skye Air Mobility, India's largest SaaS-based autonomous logistics solution provider, has bagged 10 transformative contracts from Government Healthcare service providers nationwide. In a groundbreaking achievement, Skye Air Mobility has secured transformative contracts with renowned healthcare institutions across India, including AIIMS Deoghar (Jharkhand),
Announcement made at a special session on Role of AI in Cardiology and Healthcare - Dr. Jag Singh, renowned expert in healthcare innovation from Harvard Medical School, Boston, USA, and the author of the groundbreaking book, ‘Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine’ was
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to
New strategic partnership will scale-up manufacturing capacity to support global supply of dengue vaccine and expands Takeda's footprint in vaccine manufacturing The strategic partnership will deliver potentially up to 50 million doses per year by 2030 to address global public health need Dengue is a
The project will be undertaken by Jakson Infra, with an aim to heralds a new era in medical facilities for the region With an investment of more than 600 Crores, the project will enhance healthcare services for tribal communities and the wider population of
